pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: pdufa×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07552220: Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography

    Sponsor: Centre Hospitalier de Mâcon. Phase: . Conditions: Myositis, Health Adult Subjects

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06635824: Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

    Sponsor: Genmab. Phase: PHASE3. Conditions: PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06373380: A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: EARLY_PHASE1. Conditions: HPV16+ Squamous Cell Carcinoma

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT06364280: Pediatric Prehospital Airway Resuscitation Trial

    Sponsor: Ohio State University. Phase: NA. Conditions: Heart Arrest, Out-Of-Hospital, Wounds and Injuries, Respiratory Insufficiency in Children, Child, Only, Critical Illness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07290296: Popliteus Muscle Release Versus Kinesio Taping

    Sponsor: Cairo University. Phase: NA. Conditions: Patellofemoral Pain Syndrome

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07612696: Impact of Electronic Cigarette Temperature and Solvent on Biomarkers

    Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Oxidative Stress, Tobacco Use, Electronic Cigarettes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04406662: Routine Evaluation of People Living With Cancer

    Sponsor: University of Edinburgh. Phase: . Conditions: Cachexia; Cancer, Advanced Cancer, Quality of Life

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07639762: Comparison of the Efficacy of Ultrasound-guided Supra-inguinal Fascia Iliaca and Lumbar Erector Spina Plan Block in Hip Fractures

    Sponsor: Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. Phase: . Conditions: Hip Fracture, Pain Management, Multimodal Analgesia, Peripheral Nerve Block, Lumbar Erector Spinae Plane Block, Suprainguinal Fasia Iliaca Block

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07108062: Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis

    Sponsor: Hungarian University of Sports Science. Phase: NA. Conditions: Enuresis Nocturnal, Urinary Incontinence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06295562: Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea

    Sponsor: China Medical University Hospital. Phase: PHASE4. Conditions: Obstructive Sleep Apnea of Adult

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07098962: KinesioTaping for Thoracic Drain Support

    Sponsor: Kastamonu University. Phase: PHASE2. Conditions: Primary Condition: Pain, Postoperative, Associated Conditions: Cardiac Surgical Procedures, Thoracic Surgery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01783288: Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening

    Sponsor: Vanderbilt University. Phase: NA. Conditions: Postural Tachycardia Syndrome

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07644403: Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.

    Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd. Phase: PHASE1. Conditions: Epithelial Cancer Patients

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07465627: Vessel Recoil in Specific CLTI Populations

    Sponsor: Medical University of Graz. Phase: . Conditions: Chronic Limb Threatening Ischemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06553027: To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

    Sponsor: Cerevance. Phase: PHASE3. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07541261: A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia

    Sponsor: Janssen Research & Development, LLC. Phase: . Conditions: Colitis, Ulcerative, Crohn Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06954961: A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer

    Sponsor: InventisBio Co., Ltd. Phase: PHASE3. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05617742: Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

    Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07316686: Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma

    Sponsor: Instituto do Cancer do Estado de São Paulo. Phase: PHASE1. Conditions: Prostate Cancer (Adenocarcinoma)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05176470: Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

    Sponsor: Richard Wu. Phase: PHASE1. Conditions: Locally Advanced Melanoma, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Stage IV Melanoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06285773: Recto-intercostal Fascial Plane Block and Pecto-intercostal Fascial Plane Block for Cardiac Surgery

    Sponsor: Medipol University. Phase: NA. Conditions: Cardiac Disease

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07298486: Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALS

    Sponsor: Nova Southeastern University. Phase: NA. Conditions: Amyotrophic Lateral Sclerosis (ALS)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07461870: The Mediterranean Diet Based on Local Foods for Obese Patients

    Sponsor: Indonesia University. Phase: NA. Conditions: Obese Subjects

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06714370: Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Nationwide Study

    Sponsor: Ono Pharmaceutical Co., Ltd.. Phase: . Conditions: Primary Central Nervous System Lymphoma (PCNSL)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07602270: Effects of Ketogenic Diet on Alcohol Intoxication

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Ketogenic Diet, Alcohol Drinking, Alcohol Use Disorder, Magnetic Resonance Imaging, Alcohol Intoxication

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06278883: Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase

    Sponsor: Duke University. Phase: NA. Conditions: Cardiovascular Diseases, Cancer, Liver Diseases, Hyperthermia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06603441: Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea

    Sponsor: Stanford University. Phase: . Conditions: Obstructive Sleep Apnea of Adult

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05091905: Patient-Titrated Automated Intermittent Boluses of Local Anesthetic vs. a Continuous Infusion Via a Perineural Catheter for Postoperative Analgesia

    Sponsor: University of California, San Diego. Phase: PHASE4. Conditions: Pain, Acute Postoperative, Trauma Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07423494: Personalized Antisense Oligonucleotide Therapy for A Single Patient With CHCHD10 ALS (nL18576)

    Sponsor: n-Lorem Foundation. Phase: PHASE1. Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05800366: A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

    Sponsor: Jennifer Crombie, MD. Phase: PHASE2. Conditions: Lymphoma, Lymphoma, Large B-Cell, Diffuse

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04838756: Mammography Screening With Artificial Intelligence (MASAI)

    Sponsor: Region Skane. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01793922: POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)

    Sponsor: KU Leuven. Phase: NA. Conditions: Achalasia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04555551: MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07357051: Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza

    Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd. Phase: PHASE3. Conditions: Respiratory Viral Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06539390: Impact of Sedation on Patient Satisfaction, Radiation Exposure, and Complications in Lumbar Transforaminal Epidural Steroid Injections: A Retrospective Cohort Study

    Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Pain, Chronic

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03388190: METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin

    Sponsor: University Hospital, Akershus. Phase: PHASE2. Conditions: Colorectal Cancer Metastatic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07606690: The Geniohyoid Muscle in Critical Illness

    Sponsor: Warrington Hospital. Phase: . Conditions: Mechanical Ventilation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07373418: Glucose Observation and Wearable Use for Prevention

    Sponsor: University of St.Gallen. Phase: . Conditions: Prevention

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06979518: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry

    Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Pulmonary Disease, Chronic Obstructive

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07234318: A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study

    Sponsor: Laboratoires Thea. Phase: . Conditions: Dry Eye Disease (DED)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06290713: Vasodilator and Exercise Study for DMD (VASO-REx)

    Sponsor: University of Florida. Phase: PHASE2. Conditions: Duchenne Muscular Dystrophy, Duchenne Disease, Muscular Dystrophy, Muscular Dystrophy in Children, Vasodilation, Exercise, DMD

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05881460: Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2

    Sponsor: Synergic Medical Technologies, Inc.. Phase: NA. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03910660: A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

    Sponsor: BioXcel Therapeutics Inc. Phase: PHASE1. Conditions: Prostate Cancer, Neuroendocrine Tumors, Small Cell Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07530523: KPAP vs EPR for Efficacy

    Sponsor: SleepRes Inc.. Phase: NA. Conditions: Obstructive Sleep Apnea

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05363280: Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

    Sponsor: Advenchen Pharmaceuticals, LLC.. Phase: PHASE2. Conditions: Small Cell Lung Cancer, Renal Cell Carcinoma (RCC), Non-Small Cell Lung

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04648280: Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

    Sponsor: PENTA Foundation. Phase: PHASE1. Conditions: HIV Infections With Multi Drug Resistant Virus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07435779: Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study

    Sponsor: Hebei Senlang Biotechnology Inc., Ltd.. Phase: EARLY_PHASE1. Conditions: UC

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05907096: ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

    Sponsor: argenx. Phase: PHASE2. Conditions: Delayed Graft Function

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01897688: A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients

    Sponsor: Northwestern University. Phase: PHASE3. Conditions: Type 1 Diabetes, Severe Hypoglycemic Unawareness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05431088: A Phase 2/3 Study in Adult and Adolescent Participants With SCD

    Sponsor: Pfizer. Phase: PHASE2. Conditions: Sickle Cell Disease

    full page →ctgov ↗
    ← prev
    page 80 of 104
    next →